DCB PCI: are we ready for complex de novo lesions?

Facilitators: R. Garbo, E. Regar

Speakers: D. O. Kang, R. Natarajan, X. He, D. Maximkin, R. Januszek

Summary

Evaluate the readiness of drug-coated balloon (DCB) therapy for complex de novo coronary lesions. This session reviews comparative outcomes of DCB versus drug-eluting stents (DES) across CHIP risk categories, impacts of diabetes, long-term follow-up data in calcified lesions and left main bifurcations, and treatment of in-stent restenosis in patients with chronic kidney disease.

Presentations available when logged in:

DCB-based versus DES-only strategy for de novo coronary artery disease across CHIP risk categories
A retrospective analysis of long-term outcomes of DCB vs. DES in heavily calcified lesions
Impact of diabetes on de novo lesions treated with DCB
DEB catheters for PCI of true left main bifurcations: five-year follow-up
Long-term outcomes following DCB vs. thin-strut DES for treatment of in-stent restenosis in chronic kidney disease patients

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

DCB PCI: are we ready for complex de novo lesions?

Log in or create account for free